2m 2m 2m 2m 2m 2m 2m
- $237,195.00Market Cap
- -99.64%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Stemtech (STEK)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 26
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 07/31/2026
Company Profile
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the OraStem brand; and rapid renew stem cell peptide night cream under the Collect One brand name, as well as Cellect One shield hypochlorous acid skin care products. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.
Key Executives
- Charles S. Arnold
- John W. Meyer
- Shrilakshmi Vadlapatla
- Lizette Leos
- Tufan Obuz
Current Ownership Distribution
- Other136.8M (93.58%)
- Insiders9.4M (6.42%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)